Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform



Provider of genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides nucleic acid analysis platform that measures genetic target material and variations.

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Primary Office
  • 3595 John Hopkins Court
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sequenom’s full profile, request a free trial.

Sequenom Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Merger/Acquisition 07-Sep-2016 $371M 00000 00000 Completed Profitable
17. Debt Refinancing 18-Jun-2015 0000 00000 Completed Profitable
16. Debt - General 20-Sep-2012 00000 00000 Completed Profitable
15. 2PO 25-Jan-2012 0000 00000 Completed Profitable
14. Debt - General 02-Jun-2011 0000 00000 Completed Profitable
13. PIPE 21-May-2010 000.00 00000 Completed Profitable
12. PIPE 23-Dec-2009 00.000 00000 Completed Profitable
11. PIPE 09-Mar-2009 00.000 00000 Completed Profitable
10. PIPE 19-Nov-2008 $3.6M $247M Completed Profitable
9. Secondary Transaction - Open Market 01-Aug-2008 $244M Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

Sequenom Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Sequenom Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 27-Jan-2009 000000000000000000 Biotechnology 00000 000000 00.0
Sequenom Center for Molecular Medicine 17-Nov-2008 Merger/Acquisition 000 Laboratory Services (Healthcare)
To view this company’s complete investment and acquisition history, request access »

Sequenom Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Comvest Partners PE/Buyout Minority 000 0000 000000 0
Delaware Crossing Investor Group Angel Group Minority 000 0000 000000 0
Fort Mason Capital PE/Buyout Minority 000 0000 000000 0
Global Life Science Ventures Venture Capital Minority 000 0000 000000 0
Haspa BGM PE/Buyout Majority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Sequenom Executive Team (16)

Name Title Board
Dirk van den Boom Ph.D President, Chief Executive Officer, Board Member, Chief Scientific & Chief Strategy Officer
Carolyn Beaver Chief Financial Officer & Senior Vice President
Mathias Ehrich Senior Vice President & Chief Scientific Officer
Bill Bowen Senior Vice President & General Counsel
Daniel Grosu MD Senior Vice President & Chief Medical Officer

9 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Sequenom Board Members (10)

Name Representing Role Since Contact
Catherine Mackey Ph.D Self Board Member 000 0000
Charles Slacik Sequenom Director 000 0000
David Pendarvis Sequenom Director 000 0000
Dirk van den Boom Ph.D Sequenom President, Chief Executive Officer, Board Member, Chief Scientific & Chief Strategy Officer 000 0000
John Fazio Self Director 000 0000

1 Former Board Member

You’re viewing 5 of 10 board members. Get the full list »